Painchek Ltd (PCK:ASX)

5.0¢

right-arrow Created with Sketch. 0.001 (2.04%)
MCAP $55.45M
Last trade 16.10pm 17/09/2021 20mins delayed

Latest Announcements

16/09/2021PCKPainchek Ltd
15/09/2021PCKPainchek Ltd
02/09/2021PCKPainchek Ltd
31/08/2021PCKPainchek Ltd
31/08/2021 Price SensitivePSPCKPainchek Ltd
27/08/2021PCKPainchek Ltd
2,624
MCap
20/08/2021PCKPainchek Ltd
20/08/2021PCKPainchek Ltd

Company Overview

PainChek Limited is an Australia-based company, that develops pain assessment technologies. The Company’s principal activities are development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. Its Paincheck is an Adult and Infant pain assessment applications. Its PainChek technology uses cameras in smartphones and tablets to capture a brief video of the person, which is analyzed in real time using facial recognition software to detect the presence of facial micro-expressions that are indicative of the presence of pain. Its Paincheck uses artificial intelligence (AI) to automatically assess the micro-facial features of pain. Its PainChek technology has multiple regulatory clearances, including TGA (Australia) and CE Mark (Europe) for use as a class 1 medical device to assess pain in people who are unable to reliably verbalize, such people with dementia.

PCK in the news

PainChek (PCK) is set to receive a $1.25 million cash injection from…
PainChek (PCK) has received CE Mark and UK MHRA clearances to start…
PainChek (PCK) has delivered yet another quarter of positive growth for its…
PainChek (PCK) has received CE Mark and Therapeutic Goods Administration (TGA) clearance…

Search Previous Announcements